Risk of Noncardiac Surgery and Adverse Events After Stents
Risk of Noncardiac Surgery and Adverse Events After Stents
The incremental risk of noncardiac surgery on adverse cardiac events in patients with coronary stents is related to timing of surgery following stent with the highest risk early post-stent placement and stabilizes by approximately 1%, 6 months after stenting. Elective major inpatient procedures especially in patients with DES were associated with significant reductions in the incremental risk when performed more than 6 months following coronary stent. Accordingly, these surgeries may benefit most from delay beyond 6 months.
Conclusions
The incremental risk of noncardiac surgery on adverse cardiac events in patients with coronary stents is related to timing of surgery following stent with the highest risk early post-stent placement and stabilizes by approximately 1%, 6 months after stenting. Elective major inpatient procedures especially in patients with DES were associated with significant reductions in the incremental risk when performed more than 6 months following coronary stent. Accordingly, these surgeries may benefit most from delay beyond 6 months.
